how are companies still selling compounded semaglutide Despite FDA ruling, GLP-1s giving Novo and Lilly headaches on the market The FDA's Decision to Ban

A recent study projected that people who stop taking GLP-1s would regain their lost weight within about 18 months

The UK Government MHRA warns against the misuse of falsified GLP-1RAs, often acquired without a prescription, and the growing trend of using these medications for aesthetic weight loss

Villaschi A, Ferrante G, Cannata F, Pini D, Pagnesi M, Corrada E, et al

For starters, with Henry, you work up to a lower peak dose (1 milligram per week) than researchers reached in clinical trials (2.4 mg per week)

In this case, the dynamics really do favour Lilly, and I expect the compounded tirzepatide market to shrink meaningfully over the next two years as pricing converges

You will also find products with different forms of carnitine combined